Clinical Trials Browser

Phase 1/2 × Thalidomide × Genitourinary × Clear all

NCT00038246 2018-10-31

Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma

Phase 1/2 Completed

Prostatic Neoplasms

NCT00277017 2011-09-27

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Phase 1/2 Completed

Carcinoma, Renal Cell, Neoplasms